|
| | SB1630 Engrossed | | LRB098 08625 MGM 38744 b |
|
|
| 1 | | AN ACT concerning regulation.
|
| 2 | | Be it enacted by the People of the State of Illinois,
|
| 3 | | represented in the General Assembly:
|
| 4 | | Section 5. The Medical Patient Rights Act is amended by |
| 5 | | adding Section 3.3 as follows: |
| 6 | | (410 ILCS 50/3.3 new) |
| 7 | | Sec. 3.3. Prohibition on the markup of anatomic pathology |
| 8 | | services. |
| 9 | | (a) A physician who orders, but who does not supervise or |
| 10 | | perform, an anatomic pathology service shall disclose in a bill |
| 11 | | for such service presented to the patient: |
| 12 | | (1) the name and address of the physician or laboratory
|
| 13 | | that provided the anatomic pathology service; and |
| 14 | | (2) the actual amount paid or to be paid for each |
| 15 | | anatomic pathology service provided to the patient by the |
| 16 | | physician or laboratory that performed the service. |
| 17 | | (b) A physician subject to the requirement of subsection |
| 18 | | (a) of this Section when billing a patient, insurer, or |
| 19 | | third-party payer shall not markup, or directly or indirectly |
| 20 | | increase, the amount subject to disclosure under paragraph (2) |
| 21 | | of subsection (a) of this Section in any bill presented to a |
| 22 | | patient, insurer, or third-party payer. |
| 23 | | (c) This Section does not prohibit a referring physician |
|
| | SB1630 Engrossed | - 2 - | LRB098 08625 MGM 38744 b |
|
|
| 1 | | from charging a specimen acquisition or processing charge if: |
| 2 | | (1) the charge is limited to actual costs incurred for |
| 3 | | specimen collection and transportation; and |
| 4 | | (2) the charge is separately coded or denoted as a |
| 5 | | service distinct from the performance of the anatomic |
| 6 | | pathology service, in conformance with the coding policies |
| 7 | | of the American Medical Association. |
| 8 | | (d) The requirements of this Section do not apply to an |
| 9 | | anatomic pathology service ordered or provided by: |
| 10 | | (1) facilities licensed under the Hospital Licensing |
| 11 | | Act or the University of Illinois Hospital Act or clinical |
| 12 | | laboratories owned, operated by, or operated within |
| 13 | | facilities licensed under the Hospital Licensing Act or the |
| 14 | | University of Illinois Hospital Act; |
| 15 | | (2) any public health clinic or nonprofit health |
| 16 | | clinic; or |
| 17 | | (3) any government agency, or their specified public or |
| 18 | | private agents. |
| 19 | | (e) No patient, insurer, or other third-party payer, shall |
| 20 | | be required to reimburse any licensed health care professional |
| 21 | | for charges or claims submitted in violation of this Section. |
| 22 | | (f) A person who receives a bill for an anatomic pathology |
| 23 | | service made in knowing and willful violation of this Section |
| 24 | | may maintain an action to recover the actual amount paid for |
| 25 | | the bill. |
| 26 | | (g) The Department of Insurance shall enforce the |
|
| | SB1630 Engrossed | - 3 - | LRB098 08625 MGM 38744 b |
|
|
| 1 | | provisions of this Section for any bill submitted to a payer in |
| 2 | | violation of this Section. |
| 3 | | (h) For the purposes of this Section, "anatomic pathology |
| 4 | | services" means: |
| 5 | | (1) histopathology or surgical pathology, meaning the |
| 6 | | gross and microscopic examination performed by a physician |
| 7 | | or under the supervision of a physician, including |
| 8 | | histologic processing; |
| 9 | | (2) cytopathology, meaning the microscopic examination |
| 10 | | of cells from (A) fluids, (B) aspirates, (C) washings, (D) |
| 11 | | brushings, or (E) smears, including the Pap smear test |
| 12 | | examination performed by a physician or under the |
| 13 | | supervision of a physician; |
| 14 | | (3) hematology, meaning the microscopic evaluation of |
| 15 | | bone marrow aspirates and biopsies performed by a |
| 16 | | physician, or under the supervision of a physician, and |
| 17 | | peripheral blood smears when the attending or treating |
| 18 | | physician or technologist requests that a blood smear be |
| 19 | | reviewed by a pathologist; |
| 20 | | (4) sub-cellular pathology or molecular pathology, |
| 21 | | meaning the assessment of a patient specimen for the |
| 22 | | detection, localization, measurement, or analysis of one |
| 23 | | or more protein or nucleic acid targets; and |
| 24 | | (5) blood-banking services performed by pathologists.
|